Dr. Rafael Garcia-Cortes, MD
NPI: 1013145986
Total Payments
$82,921
2024 Payments
$10,589
Companies
10
Transactions
104
Medicare Patients
3,282
Medicare Billing
$261,177
Payment Breakdown by Category
Other$71,075 (85.7%)
Travel$5,927 (7.1%)
Food & Beverage$4,419 (5.3%)
Consulting$1,500 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $71,075 | 26 | 85.7% |
| Travel and Lodging | $5,927 | 9 | 7.1% |
| Food and Beverage | $4,419 | 65 | 5.3% |
| Consulting Fee | $1,500 | 4 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $40,948 | 39 | $0 (2020) |
| PFIZER INC. | $25,563 | 12 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $13,916 | 15 | $0 (2024) |
| Abbott Laboratories | $2,058 | 28 | $0 (2023) |
| Medtronic Vascular, Inc. | $234.67 | 4 | $0 (2018) |
| EKOS Corporation | $110.91 | 1 | $0 (2019) |
| United Therapeutics Corporation | $30.94 | 1 | $0 (2017) |
| Amgen Inc. | $29.84 | 2 | $0 (2018) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $15.50 | 1 | $0 (2018) |
| Medtronic, Inc. | $14.42 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,589 | 7 | E.R. Squibb & Sons, L.L.C. ($7,464) |
| 2023 | $10,172 | 13 | E.R. Squibb & Sons, L.L.C. ($6,452) |
| 2022 | $6,240 | 5 | PFIZER INC. ($5,925) |
| 2021 | $5,050 | 2 | PFIZER INC. ($5,050) |
| 2020 | $11,914 | 9 | Novartis Pharmaceuticals Corporation ($6,598) |
| 2019 | $27,981 | 30 | Novartis Pharmaceuticals Corporation ($24,664) |
| 2018 | $10,422 | 27 | Novartis Pharmaceuticals Corporation ($9,686) |
| 2017 | $553.80 | 11 | Abbott Laboratories ($522.86) |
All Payment Transactions
104 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,375.00 | General |
| Category: Cardiovascular | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Travel and Lodging | Cash or cash equivalent | $172.86 | General |
| Category: Cardiovascular | ||||||
| 11/21/2024 | PFIZER INC. | VYNDAQEL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,125.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/23/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: Cardiovascular | ||||||
| 10/03/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $109.96 | General |
| Category: Cardiovascular | ||||||
| 07/17/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $5.80 | General |
| Category: Cardiovascular | ||||||
| 05/08/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| Category: Cardiovascular | ||||||
| 11/21/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: Cardiovascular | ||||||
| 11/02/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $127.02 | General |
| Category: Cardiovascular | ||||||
| 10/27/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $9.11 | General |
| Category: Cardiovascular | ||||||
| 10/25/2023 | PFIZER INC. | VYNDAQEL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,400.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/15/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: Cardiovascular | ||||||
| 07/27/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $109.65 | General |
| Category: Cardiovascular | ||||||
| 07/06/2023 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| 06/21/2023 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| 05/04/2023 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $77.39 | General |
| Category: Heart Failure | ||||||
| 05/04/2023 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $67.82 | General |
| Category: Heart Failure | ||||||
| 04/13/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $6.14 | General |
| 03/26/2023 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $174.40 | General |
| Category: Heart Failure | ||||||
| 02/08/2023 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| 12/21/2022 | Pfizer Inc. | VYNDAQEL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,525.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/19/2022 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $160.51 | General |
| Category: Heart Failure | ||||||
| 11/04/2022 | PFIZER INC. | VYNDAQEL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,400.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/25/2022 | Medtronic, Inc. | HVAD PUMP IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Ventricular Assist Devices | ||||||
| 07/12/2022 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $139.70 | General |
| Category: Heart Failure | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 565 | 834 | $215,003 | $52,160 |
| 2022 | 16 | 561 | 826 | $208,606 | $51,077 |
| 2021 | 22 | 874 | 1,186 | $318,758 | $71,439 |
| 2020 | 26 | 1,282 | 1,744 | $472,575 | $86,501 |
Total Patients
3,282
Total Services
4,590
Medicare Billing
$261,177
Procedure Codes
79
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 18 | 79 | $46,610 | $12,795 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 85 | 112 | $18,940 | $9,561 | 50.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 32 | 93 | $18,600 | $8,311 | 44.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 49 | 66 | $15,180 | $7,892 | 52.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 78 | 78 | $35,100 | $4,000 | 11.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 22 | 22 | $7,040 | $2,781 | 39.5% |
| 93750 | Evaluation of lower heart chamber assist device | Facility | 2023 | 22 | 77 | $6,699 | $2,252 | 33.6% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2023 | 23 | 26 | $36,920 | $2,000 | 5.4% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 45 | 56 | $7,560 | $1,014 | 13.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 40 | 41 | $3,567 | $411.16 | 11.5% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2023 | 27 | 32 | $2,528 | $319.50 | 12.6% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 28 | 34 | $4,114 | $306.90 | 7.5% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 40 | 51 | $4,845 | $261.60 | 5.4% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 12 | 12 | $1,800 | $129.12 | 7.2% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 44 | 55 | $5,500 | $124.80 | 2.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 70 | 90 | $20,700 | $10,731 | 51.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 40 | 136 | $27,200 | $9,228 | 33.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 88 | 105 | $17,850 | $9,152 | 51.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 12 | 37 | $21,830 | $6,159 | 28.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 26 | 27 | $8,640 | $3,809 | 44.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 65 | 68 | $31,297 | $3,343 | 10.7% |
| 93750 | Evaluation of lower heart chamber assist device | Facility | 2022 | 26 | 89 | $7,743 | $2,605 | 33.6% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2022 | 27 | 32 | $45,440 | $2,580 | 5.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $2,970 | $1,270 | 42.7% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2022 | 35 | 42 | $5,670 | $800.18 | 14.1% |
About Dr. Rafael Garcia-Cortes, MD
Dr. Rafael Garcia-Cortes, MD is a Advanced Heart Failure and Transplant Cardiology healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2009. The National Provider Identifier (NPI) number assigned to this provider is 1013145986.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rafael Garcia-Cortes, MD has received a total of $82,921 in payments from pharmaceutical and medical device companies, with $10,589 received in 2024. These payments were reported across 104 transactions from 10 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($71,075).
As a Medicare-enrolled provider, Garcia-Cortes has provided services to 3,282 Medicare beneficiaries, totaling 4,590 services with total Medicare billing of $261,177. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Ad
Practice Information
- Specialty Advanced Heart Failure and Transplant Cardiology
- Other Specialties Internal Medicine, Cardiovascular Disease
- Location Indianapolis, IN
- Active Since 06/30/2009
- Last Updated 06/22/2022
- Taxonomy Code 207RA0001X
- Entity Type Individual
- NPI Number 1013145986
Products in Payments
- ENTRESTO (Drug) $40,948
- VYNDAQEL (Drug) $25,563
- CAMZYOS (Drug) $12,709
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $480.12
- HeartMate 3 Left Ventricular Dev (Device) $409.15
- CardioMEMS HF System (Device) $295.46
- HeartWare HVAD (Device) $234.67
- Cardiac Mapping System (Device) $170.52
- Absorb GT1 (Device) $154.86
- Circulatory Support (Device) $150.65
- CARDIOMEMS (Device) $139.70
- Mitra Clip system (Device) $132.39
- Asahi Fielder coronary guide wire (Device) $125.00
- EKOSONIC (Device) $110.91
- ORENITRAM (Drug) $30.94
- Corlanor (Drug) $15.85
- LifeVest (Device) $15.50
- HVAD PUMP IMPLANT KIT (Device) $14.42
- Repatha (Biological) $13.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Advanced Heart Failure and Transplant Cardiology Doctors in Indianapolis
Dr. David Kovacich, M.d, M.D
Advanced Heart Failure and Transplant Cardiology — Payments: $666,196
Advanced Heart Failure and Transplant Cardiology $666,196
Dr. Sashi Adigopula, M.d, M.D
Advanced Heart Failure and Transplant Cardiology — Payments: $199,338
Advanced Heart Failure and Transplant Cardiology $199,338
Radha Kanneganti Perue, Mbbs, MBBS
Advanced Heart Failure and Transplant Cardiology — Payments: $12,622
Advanced Heart Failure and Transplant Cardiology $12,622
Angela Brittsan, M.d, M.D
Advanced Heart Failure and Transplant Cardiology — Payments: $8,661
Advanced Heart Failure and Transplant Cardiology $8,661
Joanna Pasley, Agnp-C, AGNP-C
Advanced Heart Failure and Transplant Cardiology — Payments: $465.37
Advanced Heart Failure and Transplant Cardiology $465.37
Polly Moore, Md, MD
Advanced Heart Failure and Transplant Cardiology — Payments: $231.39
Advanced Heart Failure and Transplant Cardiology $231.39